HeraMED (ASX:HMD) onboarded more than 3,800 expectant mothers onto the HeraCARE maternity monitoring and management platform as of Sept. 30, according to a Tuesday filing with the Australian bourse.
The platform currently reached a new record of 710 expectant mothers, the filing stated.
The medical data and technology company attributed its growth to US-based Broward Health, which added 207 active users in its first 100 days of going live with HeraCARE.
HeraMED's shares were up nearly 5% in recent trade.
Price (AUD): $0.02, Change: $+0.00100, Percent Change: +4.76%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。